<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>2122</number>
    <updateDate>2023-01-15T17:19:17Z</updateDate>
    <updateDateIncludingText>2023-01-15T17:19:17Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2003-05-15</introducedDate>
    <congress>108</congress>
    <committees>
      <item>
        <systemCode>hshm00</systemCode>
        <name>Homeland Security Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2003-07-09T00:13:20Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2003-06-26T21:27:27Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2003-05-15T15:13:25Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsgo00</systemCode>
        <name>Oversight and Accountability Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2003-06-12T18:17:55Z</date>
          </item>
          <item>
            <name>Markup by</name>
            <date>2003-05-22T18:15:43Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2003-05-15T15:13:20Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsas00</systemCode>
        <name>Armed Services Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Discharged from</name>
            <date>2003-06-11T23:24:51Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2003-06-11T01:21:58Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Reported by</name>
            <date>2003-06-11T00:50:32Z</date>
          </item>
          <item>
            <name>Referred to</name>
            <date>2003-05-15T15:13:15Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 108-147,Part 1</citation>
      </committeeReport>
      <committeeReport>
        <citation>H. Rept. 108-147,Part 2</citation>
      </committeeReport>
      <committeeReport>
        <citation>H. Rept. 108-147,Part 3</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Project BioShield Act of 2004</title>
        <congress>108</congress>
        <number>15</number>
        <type>S</type>
        <latestAction>
          <actionDate>2004-07-21</actionDate>
          <text>Became Public Law No: 108-276.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Companion bill</type>
            <identifiedBy>Senate</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Project BioShield Act of 2003</title>
        <congress>108</congress>
        <number>1504</number>
        <type>S</type>
        <latestAction>
          <actionDate>2003-09-02</actionDate>
          <text>Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 265.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>House</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2003-07-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 214.</text>
        <type>Calendars</type>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>17:08:00</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>17:07:59</actionTime>
        <text>On passage Passed by the Yeas and Nays: 421 - 2 (Roll no. 373).</text>
        <type>Floor</type>
        <actionCode>H37100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>373</rollNumber>
            <url>https://clerk.house.gov/evs/2003/roll373.xml</url>
            <chamber>House</chamber>
            <congress>108</congress>
            <date>2003-07-16T21:07:59Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>17:07:59</actionTime>
        <text>Passed/agreed to in House: On passage Passed by the Yeas and Nays: 421 - 2 (Roll no. 373).</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>373</rollNumber>
            <url>https://clerk.house.gov/evs/2003/roll373.xml</url>
            <chamber>House</chamber>
            <congress>108</congress>
            <date>2003-07-16T21:07:59Z</date>
            <sessionNumber>1</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>17:00:33</actionTime>
        <text>Considered as unfinished business. (consideration: CR H6947-6948)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>15:44:53</actionTime>
        <text>POSTPONED ROLL CALL VOTE - At the conclusion of debate on H.R. 2122, as amended, the Chair put the question on passage of the bill, as amended, and by voice vote, announced that the ayes had prevailed. Mr. Cox demanded the yeas and nays and the Chair postponed further proceedings on the question of passage until later in the legislative day.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>15:43:47</actionTime>
        <text>The previous question was ordered pursuant to a previous  order of the House. (consideration: CR H6946; text: CR H6946)</text>
        <type>Floor</type>
        <actionCode>H35000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>14:03:26</actionTime>
        <text>DEBATE - The House proceeded with 90 minutes of debate on H.R. 2122, equally divided and controlled.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>14:02:23</actionTime>
        <text>Considered by previous order of the House. (consideration: CR H6908-6941; text as reported in House: CR H6908-6920)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-16</actionDate>
        <actionTime>14:02:06</actionTime>
        <text>Consideration initiated by previous order of the House.</text>
        <type>Floor</type>
        <actionCode>H30800</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-07-08</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 98.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <calendarNumber>
          <calendar>U00098</calendar>
        </calendarNumber>
      </item>
      <item>
        <actionDate>2003-07-08</actionDate>
        <text>Reported (Amended) by the Committee on Homeland Security (Select). H. Rept. 108-147, Part III.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-07-08</actionDate>
        <text>Reported (Amended) by the Committee on Homeland Security (Select). H. Rept. 108-147, Part III.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-27</actionDate>
        <text>House Committee on Homeland Security (Select) Granted an extension for further consideration ending not later than July 8, 2003.</text>
        <type>IntroReferral</type>
        <actionCode>H11210</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-26</actionDate>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by the Yeas and Nays: 29 - 0.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2003-06-26</actionDate>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2003-06-13</actionDate>
        <text>House Committee on Homeland Security (Select) Granted an extension for further consideration ending not later than June 27, 2003.</text>
        <type>IntroReferral</type>
        <actionCode>H11210</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-12</actionDate>
        <text>Reported (Amended) by the Committee on Government Reform. H. Rept. 108-147, Part II.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-12</actionDate>
        <text>Reported (Amended) by the Committee on Government Reform. H. Rept. 108-147, Part II.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-11</actionDate>
        <text>Committee on Armed Services discharged.</text>
        <type>Discharge</type>
        <actionCode>H12300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsas00</systemCode>
            <name>Armed Services Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-11</actionDate>
        <text>Committee on Armed Services discharged.</text>
        <type>Committee</type>
        <actionCode>5500</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsas00</systemCode>
            <name>Armed Services Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-10</actionDate>
        <text>Referred sequentially to the House Committee on Armed Services for a period ending not later than June 11, 2003 pursuant to clause 1(c), rule X.</text>
        <type>IntroReferral</type>
        <actionCode>H11200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsas00</systemCode>
            <name>Armed Services Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-10</actionDate>
        <text>House Committee on Homeland Security (Select) Granted an extension for further consideration ending not later than June 13, 2003.</text>
        <type>IntroReferral</type>
        <actionCode>H11210</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-10</actionDate>
        <text>House Committee on Government Reform Granted an extension for further consideration ending not later than June 13, 2003.</text>
        <type>IntroReferral</type>
        <actionCode>H11210</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-10</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 108-147, Part I.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-06-10</actionDate>
        <text>Reported by the Committee on Energy and Commerce. H. Rept. 108-147, Part I.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-05-22</actionDate>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by Voice Vote.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2003-05-22</actionDate>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Government Reform, and Homeland Security (Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hshm00</systemCode>
            <name>Homeland Security Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Government Reform, and Homeland Security (Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsgo00</systemCode>
            <name>Oversight and Accountability Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Government Reform, and Homeland Security (Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100-A</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committees on Government Reform, and Homeland Security (Select), for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2003-05-15</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>T000058</bioguideId>
        <fullName>Rep. Tauzin, W. J. (Billy) [R-LA-3]</fullName>
        <firstName>W.</firstName>
        <lastName>TAUZIN</lastName>
        <party>R</party>
        <state>LA</state>
        <middleName>J.</middleName>
        <district>3</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000355</bioguideId>
        <fullName>Rep. Dingell, John D. [D-MI-15]</fullName>
        <firstName>JOHN</firstName>
        <lastName>DINGELL</lastName>
        <party>D</party>
        <state>MI</state>
        <middleName>D.</middleName>
        <district>15</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C000830</bioguideId>
        <fullName>Rep. Cox, Christopher [R-CA-48]</fullName>
        <firstName>CHRISTOPHER</firstName>
        <lastName>COX</lastName>
        <party>R</party>
        <state>CA</state>
        <district>48</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000136</bioguideId>
        <fullName>Rep. Davis, Tom [R-VA-11]</fullName>
        <firstName>THOMAS</firstName>
        <lastName>DAVIS</lastName>
        <party>R</party>
        <state>VA</state>
        <middleName>M.</middleName>
        <district>11</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M000133</bioguideId>
        <fullName>Rep. Markey, Edward J. [D-MA-7]</fullName>
        <firstName>Edward</firstName>
        <lastName>Markey</lastName>
        <party>D</party>
        <state>MA</state>
        <middleName>J.</middleName>
        <district>7</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B000463</bioguideId>
        <fullName>Rep. Bilirakis, Michael [R-FL-9]</fullName>
        <firstName>MICHAEL</firstName>
        <lastName>BILIRAKIS</lastName>
        <party>R</party>
        <state>FL</state>
        <district>9</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000114</bioguideId>
        <fullName>Rep. Davis, Jim [D-FL-11]</fullName>
        <firstName>JIM</firstName>
        <lastName>DAVIS</lastName>
        <party>D</party>
        <state>FL</state>
        <district>11</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>U000031</bioguideId>
        <fullName>Rep. Upton, Fred [R-MI-6]</fullName>
        <firstName>FRED</firstName>
        <lastName>UPTON</lastName>
        <party>R</party>
        <state>MI</state>
        <district>6</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000822</bioguideId>
        <fullName>Rep. Stearns, Cliff [R-FL-6]</fullName>
        <firstName>CLIFF</firstName>
        <lastName>STEARNS</lastName>
        <party>R</party>
        <state>FL</state>
        <district>6</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000439</bioguideId>
        <fullName>Rep. Greenwood, James C. [R-PA-8]</fullName>
        <firstName>JAMES</firstName>
        <lastName>GREENWOOD</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>C.</middleName>
        <district>8</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S000275</bioguideId>
        <fullName>Rep. Shadegg, John B. [R-AZ-3]</fullName>
        <firstName>JOHN</firstName>
        <lastName>SHADEGG</lastName>
        <party>R</party>
        <state>AZ</state>
        <district>3</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>I000056</bioguideId>
        <fullName>Rep. Issa, Darrell E. [R-CA-49]</fullName>
        <firstName>DARRELL</firstName>
        <lastName>ISSA</lastName>
        <party>R</party>
        <state>CA</state>
        <middleName>E.</middleName>
        <district>49</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000299</bioguideId>
        <fullName>Rep. Diaz-Balart, Lincoln [R-FL-21]</fullName>
        <firstName>LINCOLN</firstName>
        <lastName>DIAZ-BALART</lastName>
        <party>R</party>
        <state>FL</state>
        <district>21</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>E000215</bioguideId>
        <fullName>Rep. Eshoo, Anna G. [D-CA-14]</fullName>
        <firstName>ANNA</firstName>
        <lastName>ESHOO</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>G.</middleName>
        <district>14</district>
        <sponsorshipDate>2003-05-15</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001135</bioguideId>
        <fullName>Rep. Burr, Richard [R-NC-5]</fullName>
        <firstName>Richard</firstName>
        <lastName>Burr</lastName>
        <party>R</party>
        <state>NC</state>
        <middleName>Mauze</middleName>
        <district>5</district>
        <sponsorshipDate>2003-05-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>H000067</bioguideId>
        <fullName>Rep. Hall, Ralph M. [D-TX-4]</fullName>
        <firstName>RALPH</firstName>
        <lastName>HALL</lastName>
        <party>D</party>
        <state>TX</state>
        <middleName>M.</middleName>
        <district>4</district>
        <sponsorshipDate>2003-05-19</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <cboCostEstimates>
      <item>
        <pubDate>2003-06-06T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>http://www.cbo.gov/publication/14516</url>
        <description>&lt;p&gt;Cost estimate for the bill as ordered reported by the House Committee on Government Reform on May 22, 2003&lt;/p&gt;</description>
      </item>
      <item>
        <pubDate>2003-06-06T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>http://www.cbo.gov/publication/14523</url>
        <description>&lt;p&gt;Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on May 15, 2003&lt;/p&gt;</description>
      </item>
      <item>
        <pubDate>2003-06-06T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>https://www.cbo.gov/publication/14516</url>
        <description>Cost estimate for the bill as ordered reported by the House Committee on Government Reform on May 22, 2003</description>
      </item>
      <item>
        <pubDate>2003-06-06T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>https://www.cbo.gov/publication/14523</url>
        <description>Cost estimate for the bill as ordered reported by the House Committee on Energy and Commerce on May 15, 2003</description>
      </item>
      <item>
        <pubDate>2003-07-09T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>http://www.cbo.gov/publication/14609</url>
        <description>&lt;p&gt;Cost estimate for the bill as ordered reported by the Select Committee on Homeland Security on June 26, 2003&lt;/p&gt;</description>
      </item>
      <item>
        <pubDate>2003-07-09T04:00:00Z</pubDate>
        <title>H.R. 2122, Project BioShield Act of 2003</title>
        <url>https://www.cbo.gov/publication/14609</url>
        <description>Cost estimate for the bill as ordered reported by the Select Committee on Homeland Security on June 26, 2003</description>
      </item>
    </cboCostEstimates>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative procedure</name>
        </item>
        <item>
          <name>Armed Forces and National Security</name>
        </item>
        <item>
          <name>Authorization</name>
        </item>
        <item>
          <name>Biological warfare</name>
        </item>
        <item>
          <name>Black colleges</name>
        </item>
        <item>
          <name>Business records</name>
        </item>
        <item>
          <name>Chemical warfare</name>
        </item>
        <item>
          <name>Child health</name>
        </item>
        <item>
          <name>Clinical trials</name>
        </item>
        <item>
          <name>Commerce</name>
        </item>
        <item>
          <name>Congress</name>
        </item>
        <item>
          <name>Congressional investigations</name>
        </item>
        <item>
          <name>Congressional reporting requirements</name>
        </item>
        <item>
          <name>Crime and Law Enforcement</name>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
        </item>
        <item>
          <name>Drug approvals</name>
        </item>
        <item>
          <name>Drug industry</name>
        </item>
        <item>
          <name>Drugs</name>
        </item>
        <item>
          <name>EBB Terrorism</name>
        </item>
        <item>
          <name>Economics and Public Finance</name>
        </item>
        <item>
          <name>Education</name>
        </item>
        <item>
          <name>Emergency Management</name>
        </item>
        <item>
          <name>Emergency medicine</name>
        </item>
        <item>
          <name>Employee selection</name>
        </item>
        <item>
          <name>Export controls</name>
        </item>
        <item>
          <name>Families</name>
        </item>
        <item>
          <name>Federal aid to research</name>
        </item>
        <item>
          <name>Federal employees</name>
        </item>
        <item>
          <name>Foreign Trade and International Finance</name>
        </item>
        <item>
          <name>Government Operations and Politics</name>
        </item>
        <item>
          <name>Government contractors</name>
        </item>
        <item>
          <name>Government paperwork</name>
        </item>
        <item>
          <name>Government procurement</name>
        </item>
        <item>
          <name>Government publicity</name>
        </item>
        <item>
          <name>Government service contracts</name>
        </item>
        <item>
          <name>Higher education</name>
        </item>
        <item>
          <name>Informed consent (Medical law)</name>
        </item>
        <item>
          <name>International Affairs</name>
        </item>
        <item>
          <name>Labeling</name>
        </item>
        <item>
          <name>Laboratories</name>
        </item>
        <item>
          <name>Law</name>
        </item>
        <item>
          <name>Licenses</name>
        </item>
        <item>
          <name>Medical fees</name>
        </item>
        <item>
          <name>Medical laboratories</name>
        </item>
        <item>
          <name>Medical records</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Medical supplies</name>
        </item>
        <item>
          <name>Military medicine</name>
        </item>
        <item>
          <name>Military personnel</name>
        </item>
        <item>
          <name>Minorities</name>
        </item>
        <item>
          <name>Minority education</name>
        </item>
        <item>
          <name>Nuclear terrorism</name>
        </item>
        <item>
          <name>Peer review organizations (Medicine)</name>
        </item>
        <item>
          <name>Pharmaceutical research</name>
        </item>
        <item>
          <name>Prescription pricing</name>
        </item>
        <item>
          <name>Product safety</name>
        </item>
        <item>
          <name>Public health</name>
        </item>
        <item>
          <name>Research and development</name>
        </item>
        <item>
          <name>Research and development facilities</name>
        </item>
        <item>
          <name>Research grants</name>
        </item>
        <item>
          <name>Science, Technology, Communications</name>
        </item>
        <item>
          <name>Security measures</name>
        </item>
        <item>
          <name>Smallpox</name>
        </item>
        <item>
          <name>Storage</name>
        </item>
        <item>
          <name>Strategic materials</name>
        </item>
        <item>
          <name>Technological innovations</name>
        </item>
        <item>
          <name>Terrorism</name>
        </item>
        <item>
          <name>Vaccines</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2003-05-15</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2006-11-28T17:35:40Z</updateDate>
        <text><![CDATA[Project BioShield Act of 2003 - Amends the Public Health Service Act regarding preparations for public health emergencies affecting national security, including a bioterrorist attack.<p>Grants the Secretary of Health and Human Services (the Secretary) certain authority with respect to the research and development of qualified countermeasures, including: (1) expedited procurement authority; (2) expedited peer authority; and (3) authority for personal services contracts.<p>Directs the Secretary of Homeland Security, in coordination with the Secretary and the Secretary of Veterans Affairs, to maintain a stockpile of drugs, vaccines (including smallpox vaccine), and other supplies to provide for the emergency health security of the United States in the event of a bioterrorist attack or other public health emergency. Directs the Secretary to: (1) award grants to ensure that the stockpile contains an adequate amount of smallpox vaccine; and (2) assess, on an ongoing basis, the potential public health consequences from the use of chemical, biological, radiological, and nuclear agents and determine the agents for which countermeasures are necessary.<p>Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended for use in an emergency. Directs the Secretary to impose requirements on the authorization, including ensuring that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Allows the President, under specified circumstances in cases involving the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure.<p>Requires: (1) reports from the Secretary regarding authorities under this Act; (2) the Secretary to request the National Academy of Sciences to review biomedical countermeasure research and development activities under this Act; and (3) review by the General Accounting Office.]]></text>
      </summary>
      <summary>
        <versionCode>79</versionCode>
        <actionDate>2003-06-10</actionDate>
        <actionDesc>Reported to House without amendment</actionDesc>
        <updateDate>2003-07-31T15:43:11Z</updateDate>
        <text><![CDATA[ <p><b>(This measure has not been amended since it was introduced on May 15, 2003. However, because action occurred on the measure, the summary has been expanded.)</b></p> <p>Project BioShield Act of 2003 - (Sec. 2) Amends the Public Health Service Act regarding preparations for public health emergencies affecting national security, including a bioterrorist attack.<p>Makes biocontainment laboratories and specialized research facilities available as needed to the Secretary of Health and Human Services (the Secretary) in public health emergencies affecting national security if the owners of such a facility have entered into a grant or cooperative agreement with the Secretary under the provisions of this Act pertaining to biomedical countermeasure research and development.<p>Grants the Secretary certain authority with respect to the research and development of qualified countermeasures, including: (1) expedited procurement authority; (2) expedited peer review authority; (3) authority for personal services contracts; and (4) streamlined personnel authority. Defines a qualified countermeasure as a priority countermeasure that affects national security. <p>(Sec. 3) Directs the Secretary of Homeland Security, in coordination with the Secretary and the Secretary of Veterans Affairs, to maintain a stockpile of drugs, vaccines (including smallpox vaccine), and other supplies to provide for the emergency health security of the United States in the event of a bioterrorist attack or other public health emergency. Directs the Secretary to: (1) review and revise the contents of the stockpile on a regular basis; (2) award grants to ensure that the stockpile contains an adequate amount of smallpox vaccine; and (3) assess, on an ongoing basis, the potential public health consequences from the use of chemical, biological, radiological, and nuclear agents and determine the agents for which countermeasures are necessary. Permits the Secretary and the Secretary of Homeland Security to jointly submit to the President proposals for the development of needed security countermeasures. Defines security countermeasures as priority countermeasures against a chemical, biological, radiological, or nuclear agent that meet one of certain criteria (including having been approved or cleared under the Federal Food, Drug, and Cosmetic Act as countermeasures against a chemical, biological, radiological, or nuclear agent). <p>Amends the Homeland Security Act of 2002 to authorize appropriations for the procurement of security countermeasures.<p>(Sec. 4) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended for use in an emergency. Directs the Secretary to impose requirements on the authorization, including ensuring that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Allows the President, with regard to the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure if complying with such requirement is: (1) not feasible; (2) contrary to the best interests of such individuals; or (3) not in the interests of national security. Allows the Secretary to withhold from members of the Armed Forces information about the benefits and risks of a countermeasure and alternatives to its use if such information is provided to such individuals within 30 days of the administration of the countermeasure and is recorded in the medical records of such members.<p>Requires: (1) reports from the Secretary regarding authorities under this Act; (2) the Secretary to request the National Academy of Sciences to review biomedical countermeasure research and development activities under this Act; and (3) review by the General Accounting Office.]]></text>
      </summary>
      <summary>
        <versionCode>19</versionCode>
        <actionDate>2003-06-12</actionDate>
        <actionDesc>Reported to House amended, Part II</actionDesc>
        <updateDate>2003-08-01T20:43:45Z</updateDate>
        <text><![CDATA[ Project BioShield Act of 2003 - (Sec. 2) Amends the Public Health Service Act regarding preparations for public health emergencies affecting national security, including a bioterrorist attack. <p>Makes biocontainment laboratories and specialized research facilities available as needed to the Secretary of Health and Human Services (the Secretary) in public health emergencies affecting national security if the owners of such a facility have entered into a grant or cooperative agreement with the Secretary under the provisions of this Act pertaining to biomedical countermeasure research and development. <p>Grants the Secretary certain authority with respect to the research and development of qualified countermeasures, including: (1) expedited procurement authority; (2) expedited peer review authority; (3) authority for personal services contracts; and (4) streamlined personnel authority. Defines a qualified countermeasure as a priority countermeasure that affects national security. Declares that nothing in this section shall affect the authority of interested parties to protest contracting decisions to the contracting agency, the General Accounting Office, or the U.S. Court of Federal Claims. <p>(Sec. 3) Directs the Secretary of Homeland Security, in coordination with the Secretary and the Secretary of Veterans Affairs, to maintain a stockpile of drugs, vaccines (including smallpox vaccine), and other supplies to provide for the emergency health security of the United States in the event of a bioterrorist attack or other public health emergency. Directs the Secretary to: (1) review and revise the contents of the stockpile on a regular basis; (2) award grants to ensure that the stockpile contains an adequate amount of smallpox vaccine; and (3) assess, on an ongoing basis, the potential public health consequences from the use of chemical, biological, radiological, and nuclear agents and determine the agents for which countermeasures are necessary. Permits the Secretary and the Secretary of Homeland Security to jointly submit to the President proposals for the development of needed security countermeasures. Defines security countermeasures as priority countermeasures against a chemical, biological, radiological, or nuclear agent that meet one of certain criteria (including having been approved or cleared under the Federal Food, Drug, and Cosmetic Act as countermeasures against a chemical, biological, radiological, or nuclear agent). <p>Amends the Homeland Security Act of 2002 to authorize appropriations for the procurement of security countermeasures. <p>(Sec. 4) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended for use in an emergency. Directs the Secretary to impose requirements on the authorization, including ensuring that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Allows the President, with regard to the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure if complying with such requirement is: (1) not feasible; (2) contrary to the best interests of such individuals; or (3) not in the interests of national security. Allows the Secretary to withhold from members of the Armed Forces information about the benefits and risks of a countermeasure and alternatives to its use if such information is provided to such individuals within 30 days of the administration of the countermeasure and is recorded in the medical records of such members.<p>(Sec. 5) Requires: (1) reports from the Secretary regarding authorities under this Act; (2) the Secretary to request the National Academy of Sciences to review biomedical countermeasure research and development activities under this Act; and (3) review by the General Accounting Office.]]></text>
      </summary>
      <summary>
        <versionCode>17</versionCode>
        <actionDate>2003-07-08</actionDate>
        <actionDesc>Reported to House with amendment(s)</actionDesc>
        <updateDate>2003-07-31T15:40:01Z</updateDate>
        <text><![CDATA[ <p>Project BioShield Act of 2003 - (Sec. 2) Amends the Public Health Service Act regarding preparations for public health emergencies affecting national security, including a bioterrorist attack.</p> <p>Makes biocontainment laboratories and specialized research facilities available as needed to the Secretary of Health and Human Services (the Secretary) in public health emergencies affecting national security if the owners of such a facility have entered into a grant or cooperative agreement with the Secretary under the provisions of this Act pertaining to biomedical countermeasure research and development.<p>Grants the Secretary certain authority with respect to the research and development of qualified countermeasures, including: (1) expedited procurement authority; (2) expedited peer review authority; (3) authority for personal services contracts; and (4) streamlined personnel authority. Defines a qualified countermeasure as a priority countermeasure that affects national security. <p>(Sec. 3) Directs the Secretary of Homeland Security, in coordination with the Secretary and the Secretary of Veterans Affairs, to maintain a stockpile of drugs, vaccines (including smallpox vaccine), and other supplies to provide for the emergency health security of the United States in the event of a bioterrorist attack or other public health emergency. Directs the Secretary to: (1) review and revise the contents of the stockpile on a regular basis; (2) award grants to ensure that the stockpile contains an adequate amount of smallpox vaccine; and (3) assess, on an ongoing basis, the potential public health consequences from the use of chemical, biological, radiological, and nuclear agents and determine the agents for which countermeasures are necessary. Permits the Secretary and the Secretary of Homeland Security to jointly submit to the President proposals for the development of needed security countermeasures. Defines security countermeasures as priority countermeasures against a chemical, biological, radiological, or nuclear agent that meet one of certain criteria (including having been approved or cleared under the Federal Food, Drug, and Cosmetic Act as countermeasures against a chemical, biological, radiological, or nuclear agent). <p>Amends the Homeland Security Act of 2002 to authorize appropriations for: (1) the procurement of security countermeasures; (2) the carrying out of terror threat assessment responsibilities; (3) the acquisition and deployment of secure intelligence sharing facilities; and (4) the emergency development of security countermeasures. <p>(Sec. 4) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug or device intended for use in an emergency. Directs the Secretary to impose requirements on the authorization, including ensuring that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Allows the President, with regard to the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure if complying with such requirement is: (1) not feasible; (2) contrary to the best interests of such individuals; or (3) not in the interests of national security. Allows the Secretary to withhold from members of the Armed Forces information about the benefits and risks of a countermeasure and alternatives to its use if such information is provided to such individuals within 30 days of the administration of the countermeasure and is recorded in the medical records of such members. <p>(Sec. 5) Requires: (1) reports from the Secretary regarding particular exercises of authority; (2) the Secretary to request the National Academy of Sciences to review biomedical countermeasure research and development activities under this Act; and (3) review by the General Accounting Office. <p>(Sec. 6) Directs the Secretary to ensure that diverse institutions, including Historically Black Colleges and Universities and those serving other underrepresented populations, are meaningfully aware of research and development grants and procurements conducted under this Act. <p>(Sec. 7) Directs the Secretary, the Secretary of Homeland Security, and the Secretary of Defense to ensure that the activities of their respective Departments coordinate, complement, and do not unnecessarily duplicate programs designed to protect the homeland from biological, chemical, radiological, and nuclear agents. Directs such Secretaries to each appoint an official to coordinate such programs for their respective Departments.]]></text>
      </summary>
      <summary>
        <versionCode>36</versionCode>
        <actionDate>2003-07-16</actionDate>
        <actionDesc>Passed House amended</actionDesc>
        <updateDate>2003-07-31T15:42:24Z</updateDate>
        <text><![CDATA[ <p>Project BioShield Act of 2003 - (Sec. 2) Amends the Public Health Service Act regarding preparations for public health emergencies affecting national security, including a bioterrorist attack.</p> <p>Makes biocontainment laboratories and specialized research facilities available as needed to the Secretary of Health and Human Services (the Secretary) in public health emergencies affecting national security if the owners of such a facility have entered into a grant, contract, or cooperative agreement with the Secretary under the provisions of this Act pertaining to biomedical countermeasure research and development. <p>Grants the Secretary certain authority with respect to the research and development of qualified countermeasures, including: (1) expedited procurement authority; (2) expedited peer review authority; (3) authority for personal services contracts; and (4) streamlined personnel authority. Defines a qualified countermeasure as a priority countermeasure that affects national security. <p>(Sec. 3) Directs the Secretary of Homeland Security, in coordination with the Secretary and the Secretary of Veterans Affairs, to maintain a stockpile of drugs, vaccines (including smallpox vaccine), and other supplies to provide for the emergency health security of the United States in the event of a bioterrorist attack or other public health emergency. Directs the Secretary to: (1) review and revise the contents of the stockpile on a regular basis; (2) award grants to ensure that the stockpile contains an adequate amount of smallpox vaccine; and (3) assess, on an ongoing basis, the potential public health consequences from the use of chemical, biological, radiological, and nuclear agents and determine the agents for which countermeasures are necessary. Permits the Secretary and the Secretary of Homeland Security to jointly submit to the President proposals for the development of needed security countermeasures. Defines security countermeasures as priority countermeasures against a chemical, biological, radiological, or nuclear agent that meet one of certain criteria (including having been approved or cleared under the Federal Food, Drug, and Cosmetic Act as countermeasures against a chemical, biological, radiological, or nuclear agent). <p>Amends the Homeland Security Act of 2002 to authorize appropriations for: (1) the procurement of security countermeasures; (2) the carrying out of terror threat assessment responsibilities; and (3) the acquisition and deployment of secure intelligence sharing facilities. </p> <p>(Sec. 4) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary to declare a national emergency under specified conditions and authorize the release of a drug, device, or biological product intended for use in an emergency. Directs the Secretary to impose requirements on the authorization, including ensuring that health care professionals administering the product and persons to whom the product is administered are fully informed about the benefits and risks involved and other alternatives. Requires the Secretary to periodically review an authorization under this Act, and authorizes the Secretary to revoke such an authorization if circumstances so warrant. Allows the President, with regard to the Armed Forces, to waive the requirement that individuals be allowed to refuse administration of a countermeasure if complying with such requirement is: (1) not feasible; (2) contrary to the best interests of such individuals; or (3) not in the interests of national security. Allows the Secretary to withhold from members of the Armed Forces information about the benefits and risks of a countermeasure and alternatives to its use if such information is provided to such individuals within 30 days of the administration of the countermeasure and is recorded in the medical records of such members. <p>Requires: (1) reports from the Secretary regarding authorities under this Act; (2) the Secretary to request the National Academy of Sciences to review biomedical countermeasure research and development activities under this Act; and (3) review by the General Accounting Office. <p>(Sec. 6) Directs the Secretary to ensure that diverse institutions, including Historically Black Colleges and Universities and those serving other underrepresented populations, are meaningfully aware of research, contracts, cooperative agreements, and development grants and procurements conducted under this Act. <p>(Sec. 7) Directs the Secretary to determine whether, for any grant, contract, or cooperative agreement awarded under this Act for the research, development, or procurement of a qualified countermeasure or a security countermeasure, the countermeasure involved is subject to existing export-related controls. Allows the Secretary to make a recommendation to the appropriate agency or agencies that a countermeasure should be subject to such controls if it is not already. <p>(Sec. 8) Directs the Secretary, the Secretary of Homeland Security, and the Secretary of Defense to ensure that the activities of their respective Departments coordinate, complement, and do not unnecessarily duplicate programs designed to protect the homeland from biological, chemical, radiological, and nuclear agents. Directs such Secretaries to each appoint an official to coordinate such programs for their respective Departments.]]></text>
      </summary>
    </summaries>
    <title>Project BioShield Act of 2003</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Project BioShield Act of 2003</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To enhance research, development, procurement, and use of biomedical countermeasures to respond to public health threats affecting national security, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <title>Project BioShield Act of 2003</title>
      </item>
      <item>
        <titleType>Short Titles as Reported to House</titleType>
        <title>Project BioShield Act of 2003</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Short Titles as Passed House</titleType>
        <title>Project BioShield Act of 2003</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
      </item>
      <item>
        <titleType>Popular Titles</titleType>
        <title>Vaccine Compensation bill</title>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </titles>
    <amendments>
      <amendment>
        <number>251</number>
        <congress>108</congress>
        <type>HAMDT</type>
        <purpose>An amendment in the nature of a substitute considered as adopted pursuant to a previous order of the House.</purpose>
        <updateDate>2022-02-03T04:59:07Z</updateDate>
        <latestAction>
          <actionDate>2003-07-16</actionDate>
          <text>On agreeing to the Hastings (WA) amendment (A001) Agreed to without objection.</text>
          <actionTime>14:03:24</actionTime>
        </latestAction>
        <sponsors>
          <item>
            <bioguideId>H000329</bioguideId>
            <fullName>Rep. Hastings, Doc [R-WA-4]</fullName>
            <firstName>DOC</firstName>
            <lastName>HASTINGS</lastName>
            <party>R</party>
            <state>WA</state>
            <district>4</district>
          </item>
        </sponsors>
        <submittedDate>2003-07-16T04:00:00Z</submittedDate>
        <chamber>House of Representatives</chamber>
        <amendedBill>
          <congress>108</congress>
          <type>HR</type>
          <originChamber>House</originChamber>
          <originChamberCode>H</originChamberCode>
          <number>2122</number>
          <title>Project BioShield Act of 2003</title>
          <updateDateIncludingText>2023-01-15T17:19:17Z</updateDateIncludingText>
        </amendedBill>
        <actions>
          <count>7</count>
          <actions>
            <item>
              <actionDate>2003-07-16</actionDate>
              <actionTime>14:03:24</actionTime>
              <text>On agreeing to the Hastings (WA) amendment (A001) Agreed to without objection.</text>
              <type>Floor</type>
              <actionCode>H34111</actionCode>
              <sourceSystem>
                <code>2</code>
                <name>House floor actions</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2003-07-16</actionDate>
              <actionTime>14:02:24</actionTime>
              <text>Amendment (A001) in the nature of a substitute offered by Mr. Hastings (WA). (consideration: CR H6920-6927; text: CR H6920-6927)</text>
              <type>Floor</type>
              <actionCode>H3A100</actionCode>
              <sourceSystem>
                <code>2</code>
                <name>House floor actions</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2003-07-16</actionDate>
              <actionTime>14:02:24</actionTime>
              <text>House amendment offered/reported by : Amendment (A001) in the nature of a substitute offered by Mr. Hastings (WA).(consideration: CR H6920-6927; text: CR H6920-6927)</text>
              <type>NotUsed</type>
              <actionCode>71500</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2003-07-16</actionDate>
              <actionTime>14:03:24</actionTime>
              <text>Amendment agreed to by House: On agreeing to the Hastings (WA) amendment (A001) Agreed to without objection.</text>
              <type>NotUsed</type>
              <actionCode>79000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2003-07-16</actionDate>
              <actionTime>14:03:24</actionTime>
              <text>House amendment agreed to: On agreeing to the Hastings (WA) amendment (A001) Agreed to without objection.</text>
              <type>Floor</type>
              <actionCode>72000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
            <item>
              <actionDate>2003-07-16</actionDate>
              <text>House amendment offered</text>
              <type>Floor</type>
              <actionCode>71000</actionCode>
              <sourceSystem>
                <code>9</code>
                <name>Library of Congress</name>
              </sourceSystem>
            </item>
          </actions>
        </actions>
      </amendment>
    </amendments>
    <textVersions>
      <item>
        <type>Placed on Calendar Senate</type>
        <date>2003-07-17T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2003-07-16T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2003-07-08T04:00:00Z</date>
        <formats/>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2003-05-15T04:00:00Z</date>
        <formats/>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2003-07-17</actionDate>
      <text>Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 214.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
